Sera Publishes Validation Study of PreTRM Proteomic Test for Risk of Preterm Delivery | GenomeWeb

NEW YORK (GenomeWeb) – Researchers associated with Sera Diagnostics this week published a study in the American Journal of Obstetrics and Gynecology detailing the development and validation of the company's proteomic PreTRM test for predicting a woman's risk of preterm delivery. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.